You are here:
fluorouracil + salicylic acid (Actikerall)
Advice
following a full submission
fluorouracil 0.5% / salicylic acid 10% cutaneous solution (Actikerall®) is accepted for use within NHS Scotland.
Indication under review: the topical treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis (grade I/II) in immunocompetent adult patients.
Fluorouracil 0.5% / salicylic acid 10% cutaneous solution was superior to another topical treatment for the histological clearance of a specified target actinic keratosis lesion.
Drug Details
| Drug Name: | fluorouracil + salicylic acid (Actikerall) |
|---|---|
| SMC Drug ID: | 728/11 |
| Manufacturer: | Almirall Ltd |
| Indication: | For the topical treatment of hyperkeratotic actinic keratosis. |
| BNF Category: | |
| Sub Category: | 13.1 Management of skin conditions |
| Submission Type: | Full submission |
| Status: | Accepted |
| Date Advice Published: | 10 October 2011 |